跳至主要内容
临床试验/NCT07055009
NCT07055009招募中不适用

Multi-centred Clinico-genetic Study of Actinic Prurigo in Thailand

Chulalongkorn University2 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2025年3月30日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
47
试验地点
2
主要终点
Targeted long-read HLA sequencing

研究概览

简要总结

This research project investigates the clinical and genetic associations of Actinic Prurigo (AP) in the Thai population. As a rare chronic photodermatosis, AP has been observed to occur more frequently in individuals with certain genetic predispositions, particularly specific Human Leukocyte Antigen (HLA) types. Previous studies have suggested variations in clinical presentation and HLA allele distributions between Asian and Western populations.

The primary aim is to explore the relationship between clinical manifestations of AP and genetic profiles, including HLA typing, among Thai individuals. Additionally, the study seeks to examine whether different HLA types are associated with varying responses to treatment.

The study design is a cross-sectional comparative study, involving both AP patients and age-matched healthy controls. Given the rarity of the condition, patient recruitment will be conducted across four collaborating institutions:

King Chulalongkorn Memorial Hospital Siriraj Hospital Institute of Dermatology

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Thai ethnicity
  • Diagnosed with Actinic Prurigo (AP) according to the diagnostic criteria defined for this study
  • Mentally competent, able to communicate, and able to read Thai.
  • Participants receiving Thalidomide treatment must use two simultaneous methods of contraception, starting at least 4 weeks prior to initiating the medication and continuing throughout the treatment period and for at least 4 weeks after discontinuation.

排除标准

  • History and physical examination findings suggestive of other photodermatoses such as Lupus erythematosus, Porphyria, or Polymorphous Light Eruption, among others.
  • Elevated Epstein-Barr Virus (EBV) viral load detected in blood testing (EBV viral load will be tested in all participants).
  • Low Minimal Erythema Dose (MED) to UVB radiation as the only abnormal finding.

结局指标

主要结局

Targeted long-read HLA sequencing

时间窗: through study completion, an average of 1 year

Correlation between the occurrence of Actinic Prurigo (AP), its clinical manifestations, and genetic factors-including HLA types-in individuals of Thai ancestry.

Targeted long-read HLA sequencing

时间窗: through study completion, an average of 1 year

Correlation between the occurrence of Actinic Prurigo (AP), its clinical manifestations, and genetic factors-including HLA types-in individuals of Thai ancestry.

次要结局

  • Immunology study(through study completion, an average of 1 year)
  • Short-read whole genome sequencing (WGS)(through study completion, an average of 1 year)
  • Short-read whole genome sequencing (WGS)(through study completion, an average of 1 year)
  • Immunology study(through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Einapak Boontaveeyuwat, MD

Asst. Prof

Chulalongkorn University

研究点 (2)

Loading locations...

相似试验